{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:15:48Z","timestamp":1761513348491},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IDR"],"DOI":"10.2147\/idr.s46290","type":"journal-article","created":{"date-parts":[[2013,9,19]],"date-time":"2013-09-19T03:37:01Z","timestamp":1379561821000},"page":"93","source":"Crossref","is-referenced-by-count":26,"title":["Risk factors for infections with extended- spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden"],"prefix":"10.2147","author":[{"given":"Johan","family":"Tham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga","family":"Odenholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Walder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Melander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,9]]},"container-title":["Infection and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=17523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:34:44Z","timestamp":1477866884000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/risk-factors-for-infections-with-extended--spectrum-beta-lactamase-pro-peer-reviewed-article-IDR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/idr.s46290","relation":{},"ISSN":["1178-6973"],"issn-type":[{"value":"1178-6973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}